Emerging Trends in Immunomodulatory Nanomaterials Toward Cancer Therapy
Book 1
Book 2
Book 3
Book 1
Book 2
Book 3
Book 1
Book 2
Book 3
Book 1
Book 2
Book 3
Home > Science, Technology & Agriculture > Technology: general issues > Engineering: general > Emerging Trends in Immunomodulatory Nanomaterials Toward Cancer Therapy: (Synthesis Lectures on Biomedical Engineering)
Emerging Trends in Immunomodulatory Nanomaterials Toward Cancer Therapy: (Synthesis Lectures on Biomedical Engineering)

Emerging Trends in Immunomodulatory Nanomaterials Toward Cancer Therapy: (Synthesis Lectures on Biomedical Engineering)


     0     
5
4
3
2
1



International Edition


X
About the Book

Recently, immunomodulatory nanomaterials have gained immense attention due to their involvement in the modulation of the body’s immune response to cancer therapy. This book highlights various immunomodulatory nanomaterials (including organic, polymer, inorganic, liposomes, viral, and protein nanoparticles) and their role in cancer therapy. Additionally, the mechanism of immunomodulation is reviewed in detail. Finally, the challenges of these therapies and their future outlook are discussed. We believe this book will be helpful to a broad community including students, researchers, educators, and industrialists.

Table of Contents:
Introduction.- Immune Response and Its Role in Cancer.- Immunomodulation and Various Strategies Effecting Immune Response.- Immunomodulatory Organic and Polymer Nanomedicine in Cancer Therapy.- Immunomodulatory Liposomes in Cancer Therapy.- Immunomodulatory Protein Nanoparticles in Cancer Therapy ' Immunomodulatory Viral Nanoparticles in Cancer Therapy.- Authors' Biographies.

About the Author :
Dr. Anubhab Mukherjee completed his Ph.D. from the CSIR-Indian Institute of Chemical Technology, Hyderabad, India, having been skilled with RNAi, liposomal drug delivery in cancer, preclinical cell, and animal studies. He pursued post-doctoral research at the College of Pharmacy, Health Science Center, Texas A&M University, and was involved in another postdoctoral research at Department of Translational Neurosciences and Neurotherapeutics, John Wayne Cancer Institute, Santa Monica, California. In 2015, he worked at the Harvard-MIT Health Sciences and Technology as a visiting scientist. He has substantial experience in nanotechnology-based formulation development and successfully worked for various Indian organizations to develop pharmaceuticals and nutraceutical formulations. He is an inventor of many U.S. patents and an author of many peer-reviewed articles published in various international journals of repute. Dr. Mukherjee is currently serving as Principal Scientist, R&D at EspererOnco Nutrition (EON) Pvt. Ltd. and heads the Hyderabad R&D center of the organization.Dr. Vijay Sagar Madamsetty received his Ph.D. in chemical science from the Academy of Scientific and Innovative Research (AcSIR), India. He has had a passion for developing cutting-edge research on nanomedicine for about ten years, starting from the Council of Scientific and Industrial Research-Indian Institute of Chemical Technology (CSIR-IICT) and continuing to the present as a senior postdoctoral fellow at the Mayo Clinic Florida in the Department of Biochemistry and Molecular Biology. He is currently developing multiple drugs/genes encapsulating targeted nanoformulations and their preclinical evaluation in several dis ease animal models. Dr. Madamsetty’s long-term research inter ests involve understanding key signaling pathways and how alterations in gene expression contribute to human diseases, leading to developing effective targeted nanomedicine. He is also an active reviewer and editorialboard member of several international journals.Dr. Sudip Mukherjee completed his Ph.D. from the CSIR-Indian Institute of Chemical Technology, Hyderabad, India. Dr. Mukherjee is currently working as a Postdoctoral Research Associate at Rice University. His research is involved in the development of advanced nanomaterials for drug/gene delivery in cancer theranostics, immunomodulatory applications, and angiogenesis. He has published a total of ~50 research articles/patents. He serves as International Advisory Board Member for “Materials Research Express,” IOP Sciences. He is a member (MRSC) of RSC, UK. He serves as reviewer for several international journals such as ChemComm, Journal of Materials Chemistry A, Journal of Materials Chemistry B, Journal of Biomedical Nanotechnology, RSC Advances, and IOP Nanotechnology, Biofabrication.


Best Sellers


Product Details
  • ISBN-13: 9783031005411
  • Publisher: Springer International Publishing AG
  • Publisher Imprint: Springer International Publishing AG
  • Height: 235 mm
  • No of Pages: 84
  • Returnable: N
  • Width: 191 mm
  • ISBN-10: 3031005414
  • Publisher Date: 06 Apr 2021
  • Binding: Paperback
  • Language: English
  • Returnable: Y
  • Series Title: Synthesis Lectures on Biomedical Engineering


Similar Products

Add Photo
Add Photo

Customer Reviews

REVIEWS      0     
Click Here To Be The First to Review this Product
Emerging Trends in Immunomodulatory Nanomaterials Toward Cancer Therapy: (Synthesis Lectures on Biomedical Engineering)
Springer International Publishing AG -
Emerging Trends in Immunomodulatory Nanomaterials Toward Cancer Therapy: (Synthesis Lectures on Biomedical Engineering)
Writing guidlines
We want to publish your review, so please:
  • keep your review on the product. Review's that defame author's character will be rejected.
  • Keep your review focused on the product.
  • Avoid writing about customer service. contact us instead if you have issue requiring immediate attention.
  • Refrain from mentioning competitors or the specific price you paid for the product.
  • Do not include any personally identifiable information, such as full names.

Emerging Trends in Immunomodulatory Nanomaterials Toward Cancer Therapy: (Synthesis Lectures on Biomedical Engineering)

Required fields are marked with *

Review Title*
Review
    Add Photo Add up to 6 photos
    Would you recommend this product to a friend?
    Tag this Book Read more
    Does your review contain spoilers?
    What type of reader best describes you?
    I agree to the terms & conditions
    You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.

    CUSTOMER RATINGS AND REVIEWS AND QUESTIONS AND ANSWERS TERMS OF USE

    These Terms of Use govern your conduct associated with the Customer Ratings and Reviews and/or Questions and Answers service offered by Bookswagon (the "CRR Service").


    By submitting any content to Bookswagon, you guarantee that:
    • You are the sole author and owner of the intellectual property rights in the content;
    • All "moral rights" that you may have in such content have been voluntarily waived by you;
    • All content that you post is accurate;
    • You are at least 13 years old;
    • Use of the content you supply does not violate these Terms of Use and will not cause injury to any person or entity.
    You further agree that you may not submit any content:
    • That is known by you to be false, inaccurate or misleading;
    • That infringes any third party's copyright, patent, trademark, trade secret or other proprietary rights or rights of publicity or privacy;
    • That violates any law, statute, ordinance or regulation (including, but not limited to, those governing, consumer protection, unfair competition, anti-discrimination or false advertising);
    • That is, or may reasonably be considered to be, defamatory, libelous, hateful, racially or religiously biased or offensive, unlawfully threatening or unlawfully harassing to any individual, partnership or corporation;
    • For which you were compensated or granted any consideration by any unapproved third party;
    • That includes any information that references other websites, addresses, email addresses, contact information or phone numbers;
    • That contains any computer viruses, worms or other potentially damaging computer programs or files.
    You agree to indemnify and hold Bookswagon (and its officers, directors, agents, subsidiaries, joint ventures, employees and third-party service providers, including but not limited to Bazaarvoice, Inc.), harmless from all claims, demands, and damages (actual and consequential) of every kind and nature, known and unknown including reasonable attorneys' fees, arising out of a breach of your representations and warranties set forth above, or your violation of any law or the rights of a third party.


    For any content that you submit, you grant Bookswagon a perpetual, irrevocable, royalty-free, transferable right and license to use, copy, modify, delete in its entirety, adapt, publish, translate, create derivative works from and/or sell, transfer, and/or distribute such content and/or incorporate such content into any form, medium or technology throughout the world without compensation to you. Additionally,  Bookswagon may transfer or share any personal information that you submit with its third-party service providers, including but not limited to Bazaarvoice, Inc. in accordance with  Privacy Policy


    All content that you submit may be used at Bookswagon's sole discretion. Bookswagon reserves the right to change, condense, withhold publication, remove or delete any content on Bookswagon's website that Bookswagon deems, in its sole discretion, to violate the content guidelines or any other provision of these Terms of Use.  Bookswagon does not guarantee that you will have any recourse through Bookswagon to edit or delete any content you have submitted. Ratings and written comments are generally posted within two to four business days. However, Bookswagon reserves the right to remove or to refuse to post any submission to the extent authorized by law. You acknowledge that you, not Bookswagon, are responsible for the contents of your submission. None of the content that you submit shall be subject to any obligation of confidence on the part of Bookswagon, its agents, subsidiaries, affiliates, partners or third party service providers (including but not limited to Bazaarvoice, Inc.)and their respective directors, officers and employees.

    Accept

    Fresh on the Shelf


    Inspired by your browsing history


    Your review has been submitted!

    You've already reviewed this product!